Asset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S.
Webinar Series Summary
The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation.
Learn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. Our experts will share segment trends and break down the components of successful commercialization.
Luke Greenwalt
Vice President, Market Access Center of Excellence, IQVIA
Jennifer Millard
Vice President, Field Medical Affairs & Market Access Deployment Services, IQVIA
Flexible solutions. Responsive teams. Data-driven insights.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
